A prospective study of 24 men found that 18F-Flotufolastat PSMA PET MRI detected recurrent prostate cancer in 25 percent of ...

Oxidative stress biomarkers predicted prostate cancer recurrence risk, while LAMP5 knockdown reduced cancer cell proliferation, migration and invasion.

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

A retrospective study of 200 patients found that shortened 68Ga-PSMA PET/CT protocols miss tumor manifestations in a minority ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...

What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If there's no accompanying ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has ...

Newswise — Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their ...

Montell Jordan stood before a live audience with a powerful update on his ongoing health battle — confirming that he’s back in treatment for recurring prostate cancer while filming a documentary about ...

Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat ...

Newswise — PLYMOUTH MEETING, PA [February 9, 2026] — New research in the February 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that incorporating information from ...